profit from every $100 of sales.
$0$100
BrightSpring Health Services
$72.49+4.83% today
+128.3% in 1 year
1-year low $31.551-year high $72.91
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $75.65 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What BrightSpring Health Services sold, what it kept, and what it did with the cash.
Sales went from $7.72 billion in 2022 to $12.9 billion in 2025, with $191 million of profit last year.
SalesProfit
BrightSpring Health Services handed back 11% of the cash it generated last year.
Buybacks $43M
Free cash flow 2025$395M
Bought back its own shares$43M
Paid as dividends–
Cash vs. debt$88M vs. $2.7B
BrightSpring Health Services vs. similar companies
BrightSpring Health Services grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| BrightSpring Health Services | 75.7× · Very expensive | ||
 GE HealthCare Technologies | 18.1× · Fair price | ||
 Tempus AI | No profit yet | ||
 HealthEquity | 39.8× · Expensive | ||
 Doximity | 29.5× · Fair price |
AI analysis
An AI analyst reads BrightSpring Health Services's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 7,721 | 7,691 | 10,072 | 12,911 | |
| 1,354 | 1,139 | 1,266 | 1,518 | |
| 229 | 58 | 108 | 295 | |
| 392 | 260 | 300 | 460 | |
| -54 | -155 | -18 | 191 | |
| -0.31 | -0.90 | -0.09 | 0.87 | |
| 17.5% | 14.8% | 12.6% | 11.8% | |
| 3.0% | 0.8% | 1.1% | 2.3% | |
| -0.7% | -2.0% | -0.2% | 1.5% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 5,441 | 5,533 | 5,926 | 6,413 |
| Cash | 14 | 13 | 61 | 88 |
| Total debt | 3,677 | 3,671 | 2,789 | 2,707 |
| Total liabilities | 4,657 | 4,920 | 4,275 | 4,527 |
| 755 | 585 | 1,648 | 1,875 | |
| 171 | 171 | 193 | 220 | |
| 3.3% | 1.1% | 1.7% | 5.1% | |
| -7.1% | -26.4% | -1.1% | 10.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -5 | 211 | 24 | 490 | |
| 70 | 74 | 81 | 95 | |
| -75 | 137 | -57 | 395 | |
| Dividends paid | – | – | – | – |
| 0 | 1 | 1 | 43 | |
| 4 | 4 | 69 | 70 |
Valuation
- 75.7×
- 44.9×
- –
- 5.8×
- 1.1×
- 36.5×
- 37.1×
- 2.7%
- 1.3%
- 0.0%
Profitability
- 11.8%
- 2.3%
- 1.5%
- 4.6%
- 7.8%
- -0.0%
- 16.7%
- 5.0%
- 10.0%
- –
Growth
- +18.7%
- –
- +790.7%
- –
- +4.3%
Financial health
- 2.9×
- 1.36
- 43.5%
- 3.0×
- 1.74
- 1.38
- 2.20
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 39%of 945
Bottom 34%of 870
Bottom 13%of 559
Top 31%of 867
Top 36%of 986
What analysts expect
- Average price target
- $57.00
- Range
- $45.00 – $65.00
- 8 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 1, 2026 | 0.39 | 0.29 | +34.5% |
| Feb 27, 2026 | 0.33 | 0.34 | −2.9% |
| Oct 31, 2025 | 0.30 | 0.26 | +13.9% |
| Aug 1, 2025 | 0.22 | 0.19 | +15.8% |
| May 2, 2025 | 0.19 | 0.08 | +137.5% |
| Mar 6, 2025 | 0.22 | 0.19 | +15.8% |
| Nov 1, 2024 | 0.11 | 0.18 | −38.9% |
| Aug 2, 2024 | 0.10 | 0.17 | −41.2% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
24No pass
Benjamin Graham
16No pass
Philip Fisher
27No pass
Peter Lynch
55No pass
Joel Greenblatt
4No pass
Charlie Munger
12No pass
Terry Smith
28No pass
Questions about BrightSpring Health Services
Is BrightSpring Health Services a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the BrightSpring Health Services AI analysis
What does BrightSpring Health Services do?
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. It is in Medical - Healthcare Information Services, based in Louisville, KY, United States, with 23,500 employees.
Does BrightSpring Health Services pay a dividend?
No. BrightSpring Health Services does not pay a dividend at the moment; in 2025 it returned $43.2 million to shareholders by buying back its own shares.
Is BrightSpring Health Services stock halal?
Yes. BrightSpring Health Services passes our halal screen: its business is permitted and its debt is 20% of its market value, under the 30% limit. How we check
How has BrightSpring Health Services stock done over the past year?
Up 128.3% over the past twelve months, to $72.49. It traded between $31.55 and $72.91, close to its high.
Who are BrightSpring Health Services's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, Tempus AI, HealthEquity and Doximity. The peers table on this page compares their profit, growth and price with BrightSpring Health Services's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.